TriNetX
TriNetX, Inc. operates a global health research network that facilitates clinical research and enhances the discovery of new therapies. The company provides a suite of tools, including TriNetX Live for analyzing patient populations, TriNetX Research for accessing longitudinal clinical data, and TriNetX Download for obtaining real-world clinical data through a unified platform. Additionally, TriNetX offers Attract Trials to streamline collaboration, Natural Language Processing to extract clinical information from physician notes, and specialized oncology solutions to link researchers with clinical and genomic data. Serving healthcare organizations, biopharmaceutical companies, and contract research organizations, TriNetX aims to optimize clinical trial design and recruitment, improving the speed and efficiency of bringing new therapies to market. Established in 2013, the company is headquartered in Cambridge, Massachusetts, with additional offices in Sydney, London, and Sao Paulo.
Clinerion
Acquisition in 2023
Clinerion Ltd, headquartered in Basel, Switzerland, specializes in healthcare technology, particularly its Patient Network Explorer platform, which enhances the efficiency of clinical research and patient access to treatments. Founded in 2008, Clinerion utilizes proprietary technologies to analyze live electronic health record (EHR) data from a global network of partner hospitals, generating real-world data (RWD) that aids in understanding disease epidemiology, patient journeys, and treatment outcomes. The platform supports real-time protocol optimization, site feasibility evaluation, and patient recruitment, while also addressing diversity in clinical trials and identifying rare disease patients. Additionally, Clinerion has developed a Federated Machine Learning Platform that facilitates the training of machine learning algorithms on its RWD network, aiming to improve preventive care for patients. Committed to privacy by design, Clinerion adheres to international patient privacy and data security regulations, ensuring the integrity and confidentiality of medical data.
Advera Health Analytics
Acquisition in 2022
Advera Health Analytics is a California-based healthcare informatics company that improves patient safety and reduces systemic healthcare costs through the comprehensive analysis of post-marketing drug side effect data. Utilizing data-mining and analysis technology, through its proprietary RxSuite™ of analytics, AEI makes post-marketing drug safety data accessible, actionable, and predictable. AEI provides services to enterprise markets including managed care organizations, the pharmaceutical industry, and financial institutions.
Custodix
Acquisition in 2019
Custodix N.V. specializes in data protection solutions for the eHealth sector, focusing on the secure management of sensitive health data. The company offers a variety of products, including Custodix Anonymisation Services (CATS) for de-identifying data, the Patient Identity Management System (PAMS) for managing patient identifiers from multiple sources, and Custodix Identity and Access Management (CIAM) for overseeing identity and access in distributed environments. Additionally, Custodix provides services that enable the secure re-use of electronic health records for clinical research, as well as consultancy on data privacy and protection, ensuring compliance with European and US data protection regulations. Founded in 2000 and headquartered in Sint-Martens-Latem, Belgium, Custodix operates as a subsidiary of TriNetX, Inc. since 2019.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.